↓ Skip to main content

Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study

Overview of attention for article published in BMC Cancer, May 2013
Altmetric Badge

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
57 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study
Published in
BMC Cancer, May 2013
DOI 10.1186/1471-2407-13-248
Pubmed ID
Authors

Jianghao Chen, Qing Yao, Dong Li, Juliang Zhang, Ting Wang, Ming Yu, Xiaodong Zhou, Yi Huan, Jing Wang, Ling Wang

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Unknown 56 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 12%
Student > Bachelor 7 12%
Student > Master 6 11%
Other 5 9%
Student > Ph. D. Student 3 5%
Other 8 14%
Unknown 21 37%
Readers by discipline Count As %
Medicine and Dentistry 17 30%
Nursing and Health Professions 7 12%
Agricultural and Biological Sciences 4 7%
Biochemistry, Genetics and Molecular Biology 3 5%
Sports and Recreations 2 4%
Other 5 9%
Unknown 19 33%